# OnCo record exercise-during-chemotherapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/exercise-during-chemotherapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "exercise-during-chemotherapy" ;
  schema:name "Exercise during chemotherapy and radiotherapy"@en ;
  schema:description "Moderate exercise while on chemotherapy is safe and reduces fatigue, helps people finish their planned doses, and may protect the heart and nerves."@en ;
  schema:url <https://onco.cc/technologies/exercise-during-chemotherapy/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1249/MSS.0000000000002116>, <https://doi.org/10.1200/JCO.2014.59.1081>, <https://www.asthmaandlung.org.uk/symptoms-tests-treatments/symptoms/breathlessness>, <https://www.asthmaandlung.org.uk/symptoms-tests-treatments/symptoms/breathlessness/how-can-i-manage-my-breathlessness>, <https://www.cancerresearchuk.org/about-cancer/lung-cancer/living-with/coping-with-breathlessness>, <https://lymphoma-action.org.uk/information-and-support/living-and-beyond-lymphoma/exercise-and-lymphoma>, <https://lymphoma-action.org.uk/information-and-support/side-effects-lymphoma-and-treatment/cancer-related-fatigue> ;
  onco:status "established" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/malt-lymphoma/>, <https://onco.cc/cancers/splenic-marginal-zone-lymphoma/>, <https://onco.cc/cancers/nodal-marginal-zone-lymphoma/>, <https://onco.cc/cancers/waldenstrom/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/cancers/burkitt-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/advanced-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/relapsed-refractory-hodgkin-lymphoma/>, <https://onco.cc/cancers/nodular-lymphocyte-predominant-hodgkin-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/angioimmunoblastic-t-cell-lymphoma/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/>, <https://onco.cc/cancers/sezary-syndrome/>, <https://onco.cc/cancers/primary-cns-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/nutrition-lifestyle/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/rejuvenation/> ;
  onco:technologies <https://onco.cc/technologies/exercise-oncology/>, <https://onco.cc/technologies/cardio-oncology/>, <https://onco.cc/technologies/geriatric-assessment/> ;
  onco:terms <https://onco.cc/terms/met-hours/>, <https://onco.cc/terms/body-composition/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-workforce/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-van-waart-j-clin-oncol/>, <https://onco.cc/key-papers/paper-campbell-med-sci-sports-exerc/> .